Bioavailability, Safety, and Pharmacodynamics of Dexlansoprazole Delayed-Release Orally Disintegrating Tablets in Healthy Participants

NCT02064907 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Bioavailability

Interventions

DRUG: Dexlansoprazole Delayed Release Orally Disintegrating Tablets
DRUG: Dexlansoprazole Delayed Release Capsules

Sponsor

Takeda